Novak Djokovic has a majority stake in a Danish biotechnology firm attempting to develop a treatment for Covid-19, the London Independent has reported.
Djokovic is now back in Serbia after being deported from Australia on Sunday for failing to meet the country’s tough Covid immigration laws.
QuantBioRes boss Ivan Loncarevic has revealed that the tennis player’s acquisition of an 80 per cent stake was made in June 2020.
The company is developing a peptide, which inhibits the virus from infecting the human cell, and expects to launch clinical trials later this year.
The CEO told the media organisation the company had about a dozen researchers working in Denmark, Australia and Slovenia.
Djokovic and his wife Jelena own 40.8 per cent and 39.2 per cent of the company, respectively.
Andy Murray will make a return to the Stuttgart grass next month, two years after…
Stefanos Tsitaipas spent an hour in matching Alex de Minaur move for move to deliver…
Iga Swiatek stretched her clay court winning run to 10 consecutive matches as she schooled…
No-drama Taylor Fritz saved all 11 break points he faced and threw down 13 aces in…
Iga Swiatek came through a struggle with a fellow No. 1 as the top seed…
Stefanos Tsitsipas blasted through a tiebreaker to complete a satisfying 6-2, 7-6 win over Briton Cam…